Management of DUSHIVISHAJANYA VYANGA through VARNAKA GHRITA AND VARNYA MAHAKASHAYA ALONG WITH ORAL ADMINISTRATION OF SHIRISH CHURNA

EFFICACY OF EXTERNAL APPLICATION OF VARNAKA GHRITA AND VARNYA MAHAKASHAYA ALONG WITH ORAL ADMINISTRATION OF SHIRISH CHURNA IN DUSHIVISHAJANYA VYANGA WITH SPECIAL REFERENCE TO MELASMA - NILL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082885

Enrollment

Registered

2025-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical sign and symptoms of dushivishajany vyanga. Patients from the age group of 18 to 50 years of either sex.

Exclusion criteria

Exclusion criteria: Hyperpigmentation since birth like Nevus of Ota Age less than 18 years and more than 50 years Dushivishajanya vyanga (melasma) caused due to any systemic disease like Addison s disease, Cushing s syndrome etc. Patients having skin disease like psoriasis, leprosy, acne vulgaris, eczema and leucoderma. hyperpigmentation due to tubercular therapy or malignant cases. Dushivishajanya vyanga (melasma) caused by tumor like malignant melanoma. History of hypersensitivity. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Changes in the clinical manifestations of dushivishajanya vyangaTimepoint: 45 days	—

Secondary

Measure	Time frame
Changes in objective parameters of melasma & QOL (quality of life) of patientsTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Pappu Lal Sharma

Madan Mohan Malviya Government Ayurved College Udaipur

pappulalsharma@gmail.com9783023473

Outcome results